Rege, Rohan
Mellema, Tessa
Ramcharan, Arwin
Hoummad, Anouar Ait
Verhoeven, Sophie
Mishra, Vibhas
Jansen, Arjen J.
Ouwerkerk, Niels
Shokri, Fereshteh https://orcid.org/0000-0003-3910-5697
Article History
Accepted: 4 December 2024
First Online: 22 January 2025
Declarations
:
: All authors R.R., T.M., S. V., N. O., and F. S. were employees of Doser B.V. during this research. Doser B.V. markets the DoseRx1. N.O. is a shareholder of Doser BV.